Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Antimicrobial Agents and Chemotherapy
|
July 1, 1988
Antibacterial properties of (2,3)-alpha- and (2,3)-beta-methylene analogs of penicillin G
J G Christenson, D L Pruess, M K Talbot, et al.
Antimicrobial Agents and Chemotherapy
|
August 1, 1981
In vivo activity of ceftriaxone (Ro 13-9904), a new broad-spectrum semisynthetic cephalosporin
G Beskid, J G Christenson, R Cleeland, et al.
The American Journal of Medicine
|
August 29, 1983
Pharmacokinetics of amdinocillin and pivamdinocillin in normal volunteers
H C Neu, S Srinivasan, E L Francke, et al.
Chemosphere
|
November 9, 2016
A mechanistic study of TiO<sub>2</sub> nanoparticle toxicity on Shewanella oneidensis MR-1 with UV-containing simulated solar irradiation: Bacterial growth, riboflavin secretion, and gene expression
Tian A Qiu, Ben M Meyer, Ky G Christenson, et al.
Journal of Clinical Psychopharmacology
|
April 1, 1989
A placebo-controlled, double-blind crossover study of naltrexone hydrochloride in outpatients with normal weight bulimia
J E Mitchell, G Christenson, J Jennings, et al.
Journal of Forensic Sciences
|
October 1, 1977
Cocaine and benzoylecgonine excretion in humans
H E Hamilton, J E Wallace, E L Shimek, et al.
Antimicrobial Agents and Chemotherapy
|
October 1, 1990
Pharmacokinetics of Ro 23-9424, a dual-action cephalosporin, in animals
J G Christenson, K K Chan, R Cleeland, et al.
Critical Reviews in Microbiology
|
January 1, 1982
Correlation of the results of antibiotic synergy and susceptibility testing in vitro with results in experimental mouse infections
H D Isenberg, J Sampson-Scherer, R Cleeland, et al.
Public Health Reports (Washington, D.C. : 1974)
|
July 1, 1994
Implementing and assessing organizational practices in local health departments
B J Turnock, A Handler, W W Dyal, et al.
The American Journal of Physiology
|
November 11, 1996
An oral platelet-activating factor antagonist, Ro-24-4736, protects the rat kidney from ischemic injury
K J Kelly, N E Tolkoff-Rubin, R H Rubin, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Antimicrobial Agents and Chemotherapy
|
July 1, 1988
Antibacterial properties of (2,3)-alpha- and (2,3)-beta-methylene analogs of penicillin G
J G Christenson, D L Pruess, M K Talbot, et al.
Antimicrobial Agents and Chemotherapy
|
August 1, 1981
In vivo activity of ceftriaxone (Ro 13-9904), a new broad-spectrum semisynthetic cephalosporin
G Beskid, J G Christenson, R Cleeland, et al.
The American Journal of Medicine
|
August 29, 1983
Pharmacokinetics of amdinocillin and pivamdinocillin in normal volunteers
H C Neu, S Srinivasan, E L Francke, et al.
Chemosphere
|
November 9, 2016
A mechanistic study of TiO<sub>2</sub> nanoparticle toxicity on Shewanella oneidensis MR-1 with UV-containing simulated solar irradiation: Bacterial growth, riboflavin secretion, and gene expression
Tian A Qiu, Ben M Meyer, Ky G Christenson, et al.
Journal of Clinical Psychopharmacology
|
April 1, 1989
A placebo-controlled, double-blind crossover study of naltrexone hydrochloride in outpatients with normal weight bulimia
J E Mitchell, G Christenson, J Jennings, et al.
Journal of Forensic Sciences
|
October 1, 1977
Cocaine and benzoylecgonine excretion in humans
H E Hamilton, J E Wallace, E L Shimek, et al.
Antimicrobial Agents and Chemotherapy
|
October 1, 1990
Pharmacokinetics of Ro 23-9424, a dual-action cephalosporin, in animals
J G Christenson, K K Chan, R Cleeland, et al.
Critical Reviews in Microbiology
|
January 1, 1982
Correlation of the results of antibiotic synergy and susceptibility testing in vitro with results in experimental mouse infections
H D Isenberg, J Sampson-Scherer, R Cleeland, et al.
Public Health Reports (Washington, D.C. : 1974)
|
July 1, 1994
Implementing and assessing organizational practices in local health departments
B J Turnock, A Handler, W W Dyal, et al.
The American Journal of Physiology
|
November 11, 1996
An oral platelet-activating factor antagonist, Ro-24-4736, protects the rat kidney from ischemic injury
K J Kelly, N E Tolkoff-Rubin, R H Rubin, et al.
Page
of 3